Stock EMBLA EMBLA MEDICAL HF.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Embla Medical hf.

Equities

EMBLA

IS0000000040

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:54:34 2024-04-26 am EDT 		5-day change 1st Jan Change
29.2 DKK 0.00% Intraday chart for Embla Medical hf. -5.19% +6.38%
Apr. 23 Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024
Apr. 23 Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,310 3,380 2,720 2,029 1,708 1,785 - -
Enterprise Value (EV) 2 3,611 3,761 3,083 2,433 2,103 2,197 2,168 2,138
P/E ratio 47.8 x 414 x 41.1 x 47.6 x 28.4 x 23.7 x 19.9 x 16.5 x
Yield 0.29% 0.31% - - - - - -
Capitalization / Revenue 4.82 x 5.37 x 3.79 x 2.82 x 2.17 x 2.05 x 1.89 x 1.75 x
EV / Revenue 5.26 x 5.97 x 4.29 x 3.39 x 2.68 x 2.53 x 2.29 x 2.1 x
EV / EBITDA 24.1 x 40.4 x 20.7 x 19 x 15.1 x 13.3 x 11.6 x 11.6 x
EV / FCF 56.9 x 55.1 x 41.8 x 69.5 x 40.4 x 34.9 x 22 x 19.3 x
FCF Yield 1.76% 1.81% 2.39% 1.44% 2.47% 2.87% 4.54% 5.17%
Price to Book 5.82 x 5.79 x 4.33 x 3.26 x 2.38 x 2.2 x 2.04 x 1.83 x
Nbr of stocks (in thousands) 422,070 421,973 422,208 420,145 420,298 426,934 - -
Reference price 3 52.30 48.45 42.30 33.55 27.45 29.20 29.20 29.20
Announcement Date 2/4/20 2/2/21 2/1/22 1/31/23 1/30/24 - - -
1DKK in Million2USD in Million3DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 686.3 629.5 718.7 718.6 785.7 869.1 945 1,018
EBITDA 1 149.6 92.99 149 128.2 139.3 165.4 187.1 184.8
EBIT 1 106.1 28.29 97.31 78.84 89.39 112.3 130.1 149.6
Operating Margin 15.46% 4.49% 13.54% 10.97% 11.38% 12.92% 13.77% 14.69%
Earnings before Tax (EBT) 1 90.27 12.72 86.64 56.17 76.01 94.94 114.2 136
Net income 1 66.04 6.214 63.99 42.51 58.39 72.17 86.78 103.4
Net margin 9.62% 0.99% 8.9% 5.92% 7.43% 8.3% 9.18% 10.15%
EPS 2 1.095 0.1170 1.030 0.7053 0.9656 1.230 1.464 1.770
Free Cash Flow 1 63.43 68.22 73.84 35 52 62.95 98.38 110.5
FCF margin 9.24% 10.84% 10.27% 4.87% 6.62% 7.24% 10.41% 10.85%
FCF Conversion (EBITDA) 42.39% 73.36% 49.56% 27.31% 37.33% 38.07% 52.59% 59.8%
FCF Conversion (Net income) 96.05% 1,097.83% 115.39% 82.33% 89.06% 87.22% 113.36% 106.86%
Dividend per Share 2 0.1500 0.1500 - - - - - -
Announcement Date 2/4/20 2/2/21 2/1/22 1/31/23 1/30/24 - - -
1USD in Million2DKK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 187.5 170 180.9 176.7 190.9 181.2 201.4 192.9 210.2 199.9 222.6 211.8 232.2
EBITDA 1 - 41 27 32.88 35 33.61 28.18 37.37 36 37 33 44.85 40.25 50.3
EBIT 1 - 25.94 14 20.52 23.02 21.23 15.74 25.02 23.99 24.63 15.42 31.05 26.6 38.3
Operating Margin - 13.83% 8.24% 11.34% 13.03% 11.12% 8.69% 12.43% 12.44% 11.72% 7.72% 13.95% 12.56% 16.49%
Earnings before Tax (EBT) 1 - 23.5 12.31 19.08 8.612 16.17 13.26 20.58 18 24.17 10.98 26.8 21.9 34.3
Net income 1 -11 17.56 9 14.09 6.76 12.9 9.719 15.78 13.89 18.99 8 20.4 17 24.8
Net margin - 9.37% 5.29% 7.79% 3.83% 6.76% 5.36% 7.84% 7.2% 9.04% 4% 9.17% 8.02% 10.68%
EPS 2 - 0.2790 0.1535 0.2483 0.1193 0.2054 0.1629 0.2557 0.2327 0.3104 0.1325 0.3311 0.2789 0.4078
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 7/23/20 2/1/22 4/26/22 7/21/22 10/25/22 1/31/23 4/25/23 7/25/23 10/24/23 1/30/24 4/23/24 - - -
1USD in Million2DKK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 302 381 363 404 395 412 383 353
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.016 x 4.098 x 2.436 x 3.152 x 2.835 x 2.489 x 2.047 x 1.91 x
Free Cash Flow 1 63.4 68.2 73.8 35 52 63 98.4 111
ROE (net income / shareholders' equity) 12% 1% 11% 7% 8.91% 9.64% 10.4% 11.4%
ROA (Net income/ Total Assets) 6.59% 0.54% 5.2% 3.31% 4.38% 5.13% 5.7% 6.09%
Assets 1 1,002 1,152 1,231 1,286 1,332 1,408 1,522 1,698
Book Value Per Share 2 8.990 8.370 9.760 10.30 11.50 13.30 14.30 16.00
Cash Flow per Share 2 1.520 1.350 1.580 0.9900 1.540 2.090 2.090 2.790
Capex 1 31.9 24 26.7 25.9 42.3 37.4 37.9 43.4
Capex / Sales 4.64% 3.82% 3.71% 3.61% 5.38% 4.3% 4.01% 4.26%
Announcement Date 2/4/20 2/2/21 2/1/22 1/31/23 1/30/24 - - -
1USD in Million2DKK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Embla Medical hf.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
29.2 DKK
Average target price
34.52 DKK
Spread / Average Target
+18.22%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

1st Jan change Capi.
EMBLA MEDICAL HF. Stock Embla Medical hf.
+6.38% 1.79B
STRAUMANN HOLDING AG Stock Straumann Holding AG
+1.84% 24.07B
COCHLEAR LIMITED Stock Cochlear Limited
+7.40% 13.7B
DEMANT A/S Stock Demant A/S
+10.34% 10.18B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. Stock Eyebright Medical Technology (Beijing) Co., Ltd.
-17.75% 2.06B
ANGELALIGN TECHNOLOGY INC. Stock Angelalign Technology Inc.
+41.47% 1.73B
MODERN DENTAL GROUP LIMITED Stock Modern Dental Group Limited
+13.26% 589M
ANGEL ROBOTICS CO., LTD. Stock Angel Robotics Co., Ltd.
0.00% 400M
DELCATH SYSTEMS, INC. Stock Delcath Systems, Inc.
+27.40% 135M
INTEGRUM AB Stock Integrum AB
+21.80% 93.49M
Medical Prosthetics
  1. Stock Market
  2. Equities
  3. EMBLA Stock
  4. Financials Embla Medical hf.